Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and attachment development: Looking beyond the expected?
2024-518004-49-00Phase 2Authorised
- Sponsor
- UZ Leuven
- Start
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial comparing Oxytocin arm with Placebo arm (2 arms). Primary endpoints: Effect of oxytocin on cognitive flexibility (perseverative errors during PRLT), Effect of oxytocin on trust behaviour in 80% baseline condition (Study 1) and 2 more. Planned start Dec 2024; status: authorised.
02
Drugs
oxytocin
Beyond the preview
Go deeper on 2024-518004-49-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518004-49-00.